Mark Toland is CEO of MMI and Managing Director at BioStar Capital. He previously led Corindus, which Siemens Healthineers acquired, and was Senior Vice President at Boston Scientific. He holds a degree from the University of Louisville.
What Mark can write
Career
- Boston Scientific · Senior Vice President
- Corindus · President and CEO
- MMI · CEO
- BioStar Capital · Managing DirectorNow
Investments named in public bios
Focus
Education
Also at BioStar Capital
Alert me when BioStar Capital is active
One email when Mark's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Mark Toland?
Mark Toland is CEO of MMI and Managing Director at BioStar Capital. He previously led Corindus, which Siemens Healthineers acquired, and was Senior Vice President at Boston Scientific. He holds a degree from the University of Louisville.
How much does Mark Toland invest?
BioStar Capital has not reported a check size.
How do I pitch Mark Toland?
Email [email protected], the firm's inbox for founders, and name Mark in the subject. A warm intro from a founder BioStar Capital backed works better.
What did Mark Toland do before BioStar Capital?
Senior Vice President at Boston Scientific; President and CEO at Corindus; CEO at MMI.
Last updated 2026-10-15. Is this you? Ask for a correction.